Genzyme Corporation is a biotechnology company. The Company operates in six units. Renal develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure. Therapeutics develops, manufactures and distributes therapeutic... more

Biogen Idec Inc. is engaged in the development, manufacturing, and commercialization of therapies. The Company’s products address diseases such as multiple sclerosis, lymphoma and rheumatoid arthritis. The Company has four products: AVONEX (interferon beta-1a), RITUXAN (rituximab),... more

Schering-Plough Corporation (Schering-Plough) is a global science-based healthcare company with prescription, consumer and animal health products. Through internal research and collaborations with business partners, Schering-Plough discovers, develops, manufactures and markets advanced... more

Human Genome Sciences (HGS) is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: Albuferon for chronic hepatitis C, LymphoStat-B for systemic lupus erythematosus and ABthraxtm for inhalation anthrax. All three of these... more

GenVec, Inc. (GenVec) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer. As of December 31, 2007, TNFerade was the subject of a... more

BioVex is a biotechnology company focused on the development of novel biologics for the treatment of cancer and infectious disease. Our lead product for the treatment of cancer is OncoVEXGM-CSF. OncoVEXGM-CSF is in Phase II clinical development and is currently being tested in clinical... more

Osiris Therapeutics, Inc. (Osiris) is a stem cell therapeutic company, focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The Company’s principal biologic drug candidate, Prochymal, is being evaluated in... more

Celsion Corporation is a biotechnology company focused on developing drugs for the treatment of various cancer indications. The first of these development projects involves ThermoDox, a heat activated liposome containing doxorubicin. The Company plans to develop ThermoDox for multiple... more

Oxford BioMedica (LSE: OXB) is a biopharmaceutical company specialising in the development of novel gene-based therapeutics with a focus on the areas of oncology and neurotherapy. The Company was established in 1995 as a spin out from Oxford University, and is listed on the London Stock... more

PowderJect is the world's leading independent vaccine company. The company's headquarters are located in Oxford, UK, and it has facilities located in Europe and the US. With a range of products sold under its Evans Vaccines and SBL Vaccines brands, PowderJect is one of the world's largest... more

Ceregene strives to develop and commercialize novel gene-based neurotrophic therapies that restore vitality and function to the nervous system in disorders for which significant unmet medical needs exist, such as Alzheimer's and Parkinson's diseases. Success will be realized through our... more

Avigen, Inc. is a biopharmaceutical company engaged in developing and commercializing small molecule therapeutics to treat neurological and neuromuscular disorders. The Company’s lead product candidates primarily address spasticity, and neuromuscular spasm and neuropathic pain. Each of... more

Vical Incorporated researches and develops biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent development programs in the areas of infectious disease and... more

Neurologix, Inc. is engaged in the research and development of treatments for disorders of the brain and central nervous system, primarily utilizing gene therapies. The Company’s technology, which it refers to as NLX, is in the clinical development stages, having been tested in a Phase I... more

Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company markets one product, ReplagalÔ, for the treatment of Fabry disease in the European Union and other countries, and is developing... more

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

Viragen, Inc. (AMEX: "VRA") is a biotechnology company engaged in the research, development, manufacture and commercialization of pharmaceutical proteins for the treatment of viral diseases and cancers. Our product portfolio includes: Multiferon® (multi-subtype, natural human alpha... more

AVI BioPharma, Inc. (AVI) is a biopharmaceutical company developing therapeutic products principally based on third-generation NeuGene antisense technology. The Company’s principal products in development target life-threatening diseases, including cardiovascular, infectious, and genetic... more

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The Company is developing product candidates to treat a range of cancers using tumor... more

Athersys, Inc. is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates. In July 2007, the Company initiated a Phase I clinical trial in the United Kingdom with its lead candidate in clinical development, ATHX-105, for the treatment of... more

About Genteric, Inc. Genteric is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Using improved, non-viral and viral gene delivery techniques, Genteric's unique approach converts... more

Transgene is a France-based biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. The company has three compounds in Phase II trials (TG4001/R3484, TG4010 and TG1042) and one compound in Phase I... more

Corautus Genetics Inc. is a biopharmaceutical company dedicated to the development and commercialization of innovative gene therapy products for the treatment of cardiovascular and vascular disease. Corautus is currently developing and testing a gene therapy product using the Vascular... more

Valentis is focused on the creation of innovative cardiovascular therapeutics. The Company begins its product development at the stage of a known molecule or protein and applies its expertise in formulation, manufacturing, clinical development and regulatory affairs to create products... more

Genetix was founded by Mark Reid, its current Chief Executive, in 1991 to design and manufacture equipment and consumables for use in genomic research. Genetix has evolved by developing and launching innovative products to address the increasing demand for faster genetic research... more

Benda Pharmaceutical, Inc. (http://www.bendapharma.com ), a China-based pharmaceutical company, produces traditional Chinese and conventional medicines, as well as Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer.

Diamyd Medical AB is a biotechnology company that focuses on developing therapeutic products for diabetes and its complications. The Company licenses two technology platforms: the therapeutic rights to the gene coding for human Glutamic Acid Decarboxylase 65 (GAD65), including its uses... more

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy from becoming a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes,... more

Mologen AG is a biotechnology company researching and developing deoxyribonucleic acid (DNA)-based drugs for diseases that require a high degree of medical treatment. The Company’s activities concentrate on creating new and improving existing immunological drugs and therapies to combat... more

Chromos is a biopharmaceutical company with two drug development programs focused on inflammatory diseases and thrombotic disorders.

Mirus Bio Corporation is a biopharmaceutical company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products. Under development are RNAi gene silencing therapies based on Mirus' proprietary Dynamic PolyConjugatesÔ delivery platform... more

STEMCELL Technologies is a life sciences company dedicated to providing a range of products that support innovative research in hematology, immunology, cancer research, developmental biology, and many other areas of life science research. STEMCELL's specialized media and cell separation... more

CytoGenix, Inc. (CytoGenix) is a biopharmaceutical company whose primary focus is the development and commercialization of its technologies for identifying and silencing disease causing genes, expressing proteins for applications, such as vaccines and isolating nucleic acid-based... more

VIRxSYS corporation is a private biotech company whose mission is to develop gene therapies using its proprietary lentiviral vector delivery system. The company is in Phase II clinical trials testing the first application of its gene therapy technology against HIV, VRX496. VIRxSYS also... more

Cell Genesys, Inc. (Cell Genesys) is a biotechnology company focused on the development and commercialization of biological therapies for patients with cancer. Its clinical stage cancer programs involve cell- or viral-based products that have been modified to impart disease-fighting... more

Applied Genetic Technologies Corporation (AGTC) was founded in January, 1999 by five scientific leaders in the use of viral vectors for Gene Therapy. They subsequently secured rights to a portfolio of strategically vital intellectual property in the application of Adeno-Associated Virus... more

Nature Technology Corporation (NTC) is a technology-based biologics development company, providing vector design and construction, process development and manufacturing (OEM) assistance to biotech and bio-pharmaceutical companies. NTC's mission is to provide essential platform technology... more

Genovo, Inc., is a privately-held biotechnology company focusing on the design, and early stage clinical development of gene-based therapeutic products for the treatment of human disease. Genovo's product development pipeline includes its internal programs for hyperlipidemia,... more

Lentigen Corporation is a privately owned biotechnology company focused on the development of lentiviral vector technology for a wide range of therapeutic, vaccine, and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery... more

Virax Holdings Limited (Virax) is an Australia-based company engaged in the development of biotechnology within Australia. The Company, through its subsidiaries, is principally engaged in the construction of vectors and biologic components, and the manufacture of biologic drugs for... more

Viagene Biotech is incorporated in the state of Florida. Our company is involved in the development and production of life-science equipment and reagents. Each of us at Viagene Biotech is committed to our company's vision to play a vital role in research that leads to better lives through... more

RheoGene is developing a pipeline of indications in which RTS is the vehicle for regulated therapeutic gene delivery. Our lead program is malignant glioma, which is designed to demonstrate safety and efficacy of controlled therapeutic protein delivery to set the stage for applying RTS to... more

Aldevron offers products and services to the DNA Vaccine and Gene Therapy community. Its core technology is a proprietary method to produce and purify plasmid DNA. The company is the brainchild of North Dakota State University (NDSU) graduates John Ballantyne, from Waiuku, New Zealand,... more

Selective Genetics is a privately held biotechnology company located in San Diego, California focusing on commercializing site-specific gene therapeutics for tissue repair and regeneration.

AnGes MG, Inc. is a biopharmaceutical company founded December 1999 based on an innovative discovery by researchers of Osaka University. We specialize in R&D and practical application of genetic medicine. At present, we are engaged in developing two new medicines: the Hepatocyte Growth... more

Transkaryotic Therapies, Inc. is a biopharmaceutical company primarily focused on researching, developing and commercializing treatments for rare diseases caused by protein deficiencies. Within this focus, the company markets Replagal(TM), an enzyme replacement therapy for Fabry disease,... more

Genzyme Biosurgery is a leading developer of novel biotherapeutic and biomaterial products used to treat serious diseases. Its products and pipeline are concentrated in the rapidly growing markets of orthopaedics and heart disease and in broader surgical applications.

INCELL provides contract services to other companies. INCELL has very broad-ranging scientific and management expertise that includes: infectious disease, oncology, cell biology, toxicology, microbiology, neurobiology, gene therapy, immunology, virology, diabetes, tissue procurement,... more

Genetic Therapy, Inc. (GTI), a pioneer in gene delivery technologies, is focused on developing breakthrough solutions for cancer. GTI holds a leading position in oncolytic vectors, viruses that selectively kill cancer cells, offering the prospect of effectively treating a wide range of... more